Table 1. Characteristics of the study subjects.
Clinicopathologic features | Number | Percentage (%) |
---|---|---|
Age (years) | ||
<60 | 62 | 34.4 |
≥60 | 118 | 65.6 |
Gender | ||
male | 130 | 72.2 |
female | 50 | 17.8 |
Tumour Size (cm) | ||
<10 | 156 | 86.7 |
≥10 | 24 | 23.3 |
Tumour site | ||
cardia | 26 | 14.4 |
Non-cardia | 154 | 85.6 |
Pathological type | ||
adenocarcinoma | 176 | 97.8 |
undifferentiated carcinoma | 4 | 2.2 |
Tumour status | ||
T1+T2 | 24 | 13.4 |
T3+T4 | 155 | 86.6 |
Nodal status | ||
negative | 45 | 25.0 |
positive | 135 | 75.0 |
Metastasis status | ||
M0 | 166 | 92.2 |
M1 | 14 | 7.8 |
Tumour stage | ||
I | 17 | 9.4 |
II | 56 | 31.1 |
III | 92 | 51.1 |
IV | 14 | 7.8 |
Follow-up time (months) | 79.2-97.2 | |
Prognosis | ||
alive | 49 | 25.8 |
dead | 125 | 74.2 |
patients lived for ≥5 years | 74 | 41.1 |
patients lived for <5 years | 106 | 58.9 |